Englund G, Theodore T S, Freed E O, Engelman A, Martin M A
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
J Virol. 1995 May;69(5):3216-9. doi: 10.1128/JVI.69.5.3216-3219.1995.
Certain human immunodeficiency virus type 1 (HIV-1) isolates are able to productively infect nondividing cells of the monocyte/macrophage lineage. We have used a molecular genetic approach to construct two different HIV-1 integrase mutants that were studied in the context of an infectious, macrophage-tropic HIV-1 molecular clone. One mutant, HIV-1 delta D(35)E, containing a 37-residue deletion within the central, catalytic domain of integrase, was noninfectious in both peripheral blood mononuclear cells and monocyte-derived macrophages. The HIV-1 delta D(35)E mutant, however, exhibited defects in the assembly and/or release of progeny virions in transient transfection assays, as well as defects in entry and/or viral DNA synthesis during the early stages of monocyte-derived macrophage infection. The second mutant, HIV-1D116N/8, containing a single Asp-to-Asn substitution at the invariant Asp-116 residue of integrase, was also noninfectious in both peripheral blood mononuclear cells and monocyte-derived macrophages but, in contrast to HIV-1 delta D(35)E, was indistinguishable from wild-type virus in reverse transcriptase production. PCR analysis indicated that HIV-1D116N/8 entered monocyte-derived macrophages efficiently and reverse transcribed its RNA but was unable to complete its replication cycle because of a presumed block to integration. These data are consistent with the hypothesis that integration is an obligate step in productive HIV-1 infection of activated peripheral blood mononuclear cells and primary human macrophage cultures.
某些1型人类免疫缺陷病毒(HIV-1)分离株能够有效感染单核细胞/巨噬细胞谱系的非分裂细胞。我们采用分子遗传学方法构建了两种不同的HIV-1整合酶突变体,并在具有感染性的、嗜巨噬细胞的HIV-1分子克隆背景下对其进行研究。一种突变体HIV-1 delta D(35)E,在整合酶的中央催化结构域内有一个37个氨基酸残基的缺失,在外周血单核细胞和单核细胞衍生的巨噬细胞中均无感染性。然而,HIV-1 delta D(35)E突变体在瞬时转染试验中,子代病毒粒子的组装和/或释放存在缺陷,在单核细胞衍生的巨噬细胞感染早期的进入和/或病毒DNA合成方面也存在缺陷。第二个突变体HIV-1D116N/8,在整合酶不变的天冬氨酸-116残基处有一个单一的天冬氨酸到天冬酰胺的替换,在外周血单核细胞和单核细胞衍生的巨噬细胞中也无感染性,但与HIV-1 delta D(35)E不同的是,其逆转录酶产生与野生型病毒无差异。PCR分析表明,HIV-1D116N/8能有效进入单核细胞衍生的巨噬细胞并逆转录其RNA,但由于推测的整合障碍而无法完成其复制周期。这些数据与以下假设一致,即整合是HIV-1有效感染活化外周血单核细胞和原代人巨噬细胞培养物的必要步骤。